Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care
Hartmut Döhner(University Hospital Ulm), Hervé Dombret(University of London Institute in Paris), Mark D. Minden(University Health Network), Lars Bullinger(Stanford University), Anna Dolnik(University Hospital Ulm), S. Songer, Haifa Kathrin Al‐Ali(University Hospital in Halle), Kyle J. MacBeth(Unknown), Richard M. Stone(Dana-Farber Cancer Institute), Paresh Vyas(University of Oxford), Nora Tu, John F. Seymour(The Royal Melbourne Hospital), Valeria Santini(Azienda Ospedaliero-Universitaria Careggi), Lin Tang(Jiangxi Pingxiang People's Hospital), Barry Skikne(Boston Children's Hospital), C.L. Beach(Université Paris Cité)
Cited by 136
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k